Molbio Diagnostics Ltd vs Nexus Surgical And Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Nexus Surgical and Medicare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Nexus Surgical and Medicare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of Molbio Diagnostics Ltd is ₹ 100.47 crore as of Jun '25 .The Revenue of Nexus Surgical and Medicare Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Molbio Diagnostics Ltd is ₹ -15.35 crore as of Jun '25 .The EBITDA of Nexus Surgical and Medicare Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Molbio Diagnostics Ltd is ₹ -23.94 crore as of Jun '25 .The Net Profit of Nexus Surgical and Medicare Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Nexus Surgical and Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Nexus Surgical and Medicare Ltd

Nexus Surgical & Medicare Limited was formerly incorporated as Nexus Commodities and Technologies Limited in 1992.
The Company came out with a public issue in Aug.'96 to part-finance the project.
Later, the name of the Company was changed to Nexus Surgical & Medicare Limited in August 2020.
The Company is engaged into trading of medical essentials.
Prior to this, it was promoted by a group of technocrats to manufacture and market premium consumer durables and domestic appliances. The Company is a wholesale dealer dealing in various sizes of disposal syringe (with and without needle) and pouches of various size used for storage of sterilized equipment and materials.

FAQs for the comparison of null and Nexus Surgical and Medicare Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Nexus Surgical and Medicare Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Nexus Surgical and Medicare Ltd is 13 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Nexus Surgical and Medicare Ltd?

The stock performance of Molbio Diagnostics Ltd and Nexus Surgical and Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Nexus Surgical and Medicare Ltd?

As of October 24, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Nexus Surgical and Medicare Ltd stock price is INR ₹25.05.

How do dividend payouts of Molbio Diagnostics Ltd and Nexus Surgical and Medicare Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Nexus Surgical and Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.